Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gehrig

Showing results (131-140 of 193) with videos related to

Pageof 20
Sort By:
Nature Genetics|November 5, 1997
Positional cloning of the gene associated with X-linked juvenile retinoschisisC G Sauer, A Gehrig, R Warneke-Wittstock, et al.
Gynecologic Oncology|June 1, 2014
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N Schointuch, Timothy P Gilliam, Jessica E Stine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine LeiomyosarcomaDario R Roque, Kristin N Taylor, Marguerite Palisoul, et al.
Oncotarget|March 13, 2015
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Oncotarget|April 24, 2026
Retraction: JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Oncotarget|April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancerAnuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 18, 2011
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathwaysAlbert Mendivil, Chunxiao Zhou, Leigh A Cantrell, et al.
Gynecologic Oncology Reports|October 2, 2015
Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancerChelsea Zhang, Dario Roque, Jessie A Ehrisman, et al.
Gynecologic Oncology|March 20, 2012
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancerRobin A Laskey, Marek S Poniewierski, Micael A Lopez, et al.
Pageof 20

Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
Nature Genetics|November 5, 1997
Positional cloning of the gene associated with X-linked juvenile retinoschisisC G Sauer, A Gehrig, R Warneke-Wittstock, et al.
Gynecologic Oncology|June 1, 2014
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N Schointuch, Timothy P Gilliam, Jessica E Stine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine LeiomyosarcomaDario R Roque, Kristin N Taylor, Marguerite Palisoul, et al.
Oncotarget|March 13, 2015
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Oncotarget|April 24, 2026
Retraction: JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerHaifeng Qiu, Amanda L Jackson, Joshua E Kilgore, et al.
Gynecologic Oncology|June 30, 2009
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, et al.
Oncotarget|April 14, 2016
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancerAnuj Suri, Xiugui Sheng, Kevin M Schuler, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 18, 2011
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathwaysAlbert Mendivil, Chunxiao Zhou, Leigh A Cantrell, et al.
Gynecologic Oncology Reports|October 2, 2015
Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancerChelsea Zhang, Dario Roque, Jessie A Ehrisman, et al.
Gynecologic Oncology|March 20, 2012
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancerRobin A Laskey, Marek S Poniewierski, Micael A Lopez, et al.
Pageof 20